JLE

European Journal of Dermatology

MENU

Nail alterations secondary to pactitaxel therapy Volume 10, numéro 2, March 2000

Auteurs
Departments of Dermatology and Family Medicine, Hospital Juan Canalejo, Xubias de Arriba 84, 15006 La Coruña, Spain. Almagro@canalejo.org
  • Page(s) : 146-7
  • Année de parution : 2000

Onycholysis is an infrequent secondary effect of drug therapy, the antineoplastic agents being the drugs usually implicated. Docetaxel, a drug pertaining to the taxanes family, has been recently associated with nail bed dyschromia and onycholysis [1]. Similar alterations secondary to another chemically related antineoplastic drug, paclitaxel, have been described, but they are rare. We observed two patients with nail alterations induced by paclitaxel [...]